Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Ur Energy stock logo

1. Ur Energy NYSEAMERICAN:URG

$1.29 -0.05 (-3.73%)
Closing price 09/11/2026 04:10 PM Eastern
Extended Trading
$1.30 +0.01 (+0.78%)
As of 09/11/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$512.63 million
Consensus Rating
Buy
Consensus Price Target
$2.32 (+79.6% Upside)
Volume
5.21 million shares
Average Volume
4.95 million shares
Today's Range
$1.28
▼
$1.36
CuriosityStream stock logo

2. CuriosityStream NASDAQ:CURI

$2.66 -0.05 (-1.85%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$2.64 -0.02 (-0.71%)
As of 09/11/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CuriosityStream Inc operates as a factual content streaming service and media company. The company provides premium video and audio programming services in various categories of factual entertainment, including science, history, society, nature, lifestyle, and technology through direct subscription video on-demand (SVoD) platforms accessible by internet connected devices, or indirectly via distribution partners who deliver CuriosityStream content via distributor's platform or system, as well as through bundled content licenses for SVoD and linear offerings, talks and courses, and partner bulk sales. More about CuriosityStream

Market Capitalization
$157.84 million
P/E Ratio
266.00
Consensus Rating
Buy
Consensus Price Target
$5.50 (+106.8% Upside)
Volume
447,199 shares
Average Volume
1.28 million shares
Nouveau Monde Graphite stock logo

3. Nouveau Monde Graphite NYSE:NMG

$1.34 -0.01 (-0.37%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$1.34 0.00 (-0.37%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nouveau Monde Graphite Inc engages in the acquisition, exploration, development, and evaluation of mineral properties in Quebec, Canada. More about Nouveau Monde Graphite

Market Capitalization
$444.36 million
Consensus Rating
Buy
Consensus Price Target
$4.67 (+247.0% Upside)
Volume
390,790 shares
Average Volume
371,666 shares
Today's Range
$1.34
▼
$1.37
iBio stock logo

4. iBio NASDAQ:IBIO

$1.20 -0.02 (-1.63%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$1.24 +0.03 (+2.49%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBio

Market Capitalization
$77.49 million
Consensus Rating
Buy
Consensus Price Target
$5.00 (+314.9% Upside)
Volume
184,847 shares
Average Volume
726,921 shares
Today's Range
$1.20
▼
$1.24
Larimar Therapeutics stock logo

5. Larimar Therapeutics NASDAQ:LRMR

$3.92 +0.07 (+1.82%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$3.96 +0.04 (+1.07%)
As of 09/11/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Larimar Therapeutics, Inc, a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. More about Larimar Therapeutics

Market Capitalization
$407.22 million
Consensus Rating
Buy
Consensus Price Target
$11.67 (+197.6% Upside)
Volume
2.13 million shares
Average Volume
818,708 shares
Today's Range
$3.85
▼
$4.07
Inventiva stock logo

6. Inventiva NASDAQ:IVA

$4.02 -0.12 (-2.90%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$4.05 +0.03 (+0.85%)
As of 09/11/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. More about Inventiva

Market Capitalization
$834.98 million
Consensus Rating
Buy
Consensus Price Target
$15.38 (+282.5% Upside)
Volume
1.71 million shares
Average Volume
832,117 shares
Today's Range
$3.91
▼
$4.26
Galiano Gold stock logo

7. Galiano Gold NYSEAMERICAN:GAU

$2.16 0.00 (0.00%)
Closing price 09/11/2026 04:10 PM Eastern
Extended Trading
$2.20 +0.04 (+1.71%)
As of 09/11/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Galiano Gold Inc engages in the exploration and evaluation of gold properties in Canada. Its flagship asset is the Asanko Gold Mine that covers an area of approximately 21,000 hectares located in Ghana, West Africa. More about Galiano Gold

Market Capitalization
$564.90 million
P/E Ratio
8.31
Consensus Rating
Buy
Consensus Price Target
$4.25 (+96.8% Upside)
Volume
2.06 million shares
Average Volume
2.62 million shares
Niagen Bioscience stock logo

8. Niagen Bioscience NASDAQ:NAGE

$3.04 0.00 (0.00%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$3.04 0.00 (0.00%)
As of 09/11/2026 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Niagen Bioscience, Inc is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. More about Niagen Bioscience

Market Capitalization
$242.12 million
P/E Ratio
16.89
Consensus Rating
Buy
Consensus Price Target
$10.33 (+239.9% Upside)
Volume
321,464 shares
Average Volume
394,560 shares
Uranium Royalty stock logo

9. Uranium Royalty NASDAQ:UROY

$4.36 -0.14 (-3.11%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$4.40 +0.04 (+0.85%)
As of 09/11/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Uranium Royalty Corp. operates as a pure-play uranium royalty company. It acquires, accumulates, and manages a portfolio of geographically diversified uranium interests. More about Uranium Royalty

Market Capitalization
$1.66 billion
P/E Ratio
218.11
Consensus Rating
Buy
Consensus Price Target
$4.13 (-5.4% Downside)
Volume
3.10 million shares
Average Volume
2.45 million shares
Palisade Bio stock logo

10. Palisade Bio NASDAQ:PALI

$2.06 +0.05 (+2.49%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$2.06 0.00 (-0.19%)
As of 09/11/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade Bio

Market Capitalization
$359 million
Consensus Rating
Buy
Consensus Price Target
$9.00 (+336.9% Upside)
Volume
2.40 million shares
Average Volume
1.65 million shares
Today's Range
$2.02
▼
$2.10
Inhibikase Therapeutics stock logo

11. Inhibikase Therapeutics NASDAQ:IKT

$2.34 +0.01 (+0.43%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$2.33 -0.01 (-0.43%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase Therapeutics

Market Capitalization
$326.51 million
Consensus Rating
Buy
Consensus Price Target
$5.40 (+130.8% Upside)
Volume
303,243 shares
Average Volume
375,483 shares
Today's Range
$2.32
▼
$2.39
Lexeo Therapeutics stock logo

12. Lexeo Therapeutics NASDAQ:LXEO

$4.25 -0.11 (-2.52%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$4.24 0.00 (-0.12%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Lexeo Therapeutics, Inc operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. More about Lexeo Therapeutics

Market Capitalization
$348.70 million
Consensus Rating
Buy
Consensus Price Target
$18.75 (+341.2% Upside)
Volume
1.49 million shares
Average Volume
589,082 shares
Today's Range
$4.21
▼
$4.48
Stereotaxis stock logo

13. Stereotaxis NYSEAMERICAN:STXS

$1.29 -0.01 (-0.77%)
Closing price 09/11/2026 04:10 PM Eastern
Extended Trading
$1.33 +0.04 (+2.87%)
As of 09/11/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about Stereotaxis

Market Capitalization
$129.26 million
Consensus Rating
Buy
Consensus Price Target
$3.50 (+171.3% Upside)
Volume
473,082 shares
Average Volume
496,117 shares
Today's Range
$1.28
▼
$1.35
Perspective Therapeutics stock logo

14. Perspective Therapeutics NYSEAMERICAN:CATX

$2.81 +0.04 (+1.44%)
Closing price 09/11/2026 04:10 PM Eastern
Extended Trading
$2.73 -0.08 (-2.95%)
As of 09/11/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization
$320.77 million
Consensus Rating
Buy
Consensus Price Target
$11.50 (+309.3% Upside)
Volume
2.02 million shares
Average Volume
993,896 shares
Today's Range
$2.67
▼
$2.83
Immuneering stock logo

15. Immuneering NASDAQ:IMRX

$4.27 -0.30 (-6.56%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$4.34 +0.07 (+1.52%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. More about Immuneering

Market Capitalization
$276.26 million
Consensus Rating
Buy
Consensus Price Target
$17.50 (+309.8% Upside)
Volume
901,397 shares
Average Volume
598,160 shares
Today's Range
$4.24
▼
$4.65
Compugen stock logo

16. Compugen NASDAQ:CGEN

$2.47 +0.01 (+0.41%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$2.47 0.00 (0.00%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. More about Compugen

Market Capitalization
$233.55 million
P/E Ratio
6.50
Consensus Rating
Buy
Consensus Price Target
$5.00 (+102.4% Upside)
Volume
162,163 shares
Average Volume
294,452 shares
Equillium stock logo

17. Equillium NASDAQ:EQ

$2.11 -0.31 (-12.81%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$2.13 +0.02 (+1.18%)
As of 09/11/2026 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Equillium, Inc, a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. More about Equillium

Market Capitalization
$133.79 million
Consensus Rating
Moderate Buy
Consensus Price Target
$7.57 (+258.8% Upside)
Volume
552,173 shares
Average Volume
390,214 shares
Today's Range
$2.11
▼
$2.46
Ovid Therapeutics stock logo

18. Ovid Therapeutics NASDAQ:OVID

$2.69 +0.06 (+2.28%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$2.66 -0.03 (-1.12%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization
$525.35 million
Consensus Rating
Moderate Buy
Consensus Price Target
$6.00 (+123.0% Upside)
Volume
1.15 million shares
Average Volume
1.40 million shares
Today's Range
$2.64
▼
$2.73
Prime Medicine stock logo

19. Prime Medicine NASDAQ:PRME

$3.13 -0.22 (-6.57%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$3.18 +0.05 (+1.50%)
As of 09/11/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

We are a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, Prime Editors, to address the widest spectrum of diseases by deploying our Prime Editing technology, which we believe is a versatile, precise, efficient and broad gene editing technology. More about Prime Medicine

Market Capitalization
$567.71 million
Consensus Rating
Moderate Buy
Consensus Price Target
$7.47 (+138.7% Upside)
Volume
3.07 million shares
Average Volume
2.59 million shares
Today's Range
$3.10
▼
$3.44
Aquestive Therapeutics stock logo

20. Aquestive Therapeutics NASDAQ:AQST

$4.78 -0.21 (-4.21%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$4.76 -0.02 (-0.44%)
As of 09/11/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aquestive Therapeutics, Inc operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. More about Aquestive Therapeutics

Market Capitalization
$599.95 million
Consensus Rating
Moderate Buy
Consensus Price Target
$9.17 (+91.8% Upside)
Volume
4.14 million shares
Average Volume
2.96 million shares
Today's Range
$4.74
▼
$5.13
Foghorn Therapeutics stock logo

21. Foghorn Therapeutics NASDAQ:FHTX

$4.42 -0.07 (-1.56%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$4.51 +0.09 (+2.04%)
As of 09/11/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Foghorn Therapeutics Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. More about Foghorn Therapeutics

Market Capitalization
$262.48 million
Consensus Rating
Moderate Buy
Consensus Price Target
$11.43 (+158.6% Upside)
Volume
289,116 shares
Average Volume
377,737 shares
Today's Range
$4.37
▼
$4.62
Compass Therapeutics stock logo

22. Compass Therapeutics NASDAQ:CMPX

$2.00 -0.05 (-2.44%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$2.03 +0.03 (+1.50%)
As of 09/11/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Compass Therapeutics, Inc, a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. More about Compass Therapeutics

Market Capitalization
$360.18 million
Consensus Rating
Moderate Buy
Consensus Price Target
$11.77 (+488.5% Upside)
Volume
4.83 million shares
Average Volume
2.21 million shares
Today's Range
$1.96
▼
$2.09
Autolus Therapeutics stock logo

23. Autolus Therapeutics NASDAQ:AUTL

$1.88 -0.08 (-4.08%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$1.91 +0.03 (+1.60%)
As of 09/11/2026 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus Therapeutics

Market Capitalization
$500.39 million
Consensus Rating
Moderate Buy
Consensus Price Target
$10.00 (+431.9% Upside)
Volume
1.72 million shares
Average Volume
2.17 million shares
Today's Range
$1.87
▼
$1.98
Gold Royalty stock logo

24. Gold Royalty NYSEAMERICAN:GROY

$3.41 +0.13 (+3.96%)
Closing price 09/11/2026 04:10 PM Eastern
Extended Trading
$3.44 +0.03 (+0.88%)
As of 09/11/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Gold Royalty Corp., a precious metals-focused royalty company, provides financing solutions to the metals and mining industry. More about Gold Royalty

Market Capitalization
$787.06 million
P/E Ratio
341.34
Consensus Rating
Moderate Buy
Consensus Price Target
$5.64 (+65.5% Upside)
Volume
6.58 million shares
Average Volume
1.92 million shares
Tenaya Therapeutics stock logo

25. Tenaya Therapeutics NASDAQ:TNYA

$0.64 -0.01 (-1.36%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$0.65 +0.01 (+1.56%)
As of 09/11/2026 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya Therapeutics

Market Capitalization
$143.51 million
Consensus Rating
Moderate Buy
Consensus Price Target
$4.00 (+525.0% Upside)
Volume
1.36 million shares
Average Volume
1.71 million shares
Today's Range
$0.64
▼
$0.67

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas